Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease

Many biochemical, immunological, and neuropsychiatric changes are associated with end-stage renal disease (ESRD). Neuronal damage biomarkers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), S100 calcium-binding protein B (S100B), ionized calcium-binding adaptor molecu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of affective disorders 2024-02, Vol.347, p.220-229
Hauptverfasser: Al-Hakeim, Hussein Kadhem, Twaij, Basim Abd Al-Raheem, Al-Naqeeb, Tabarek Hadi, Moustafa, Shatha Rouf, Maes, Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 229
container_issue
container_start_page 220
container_title Journal of affective disorders
container_volume 347
creator Al-Hakeim, Hussein Kadhem
Twaij, Basim Abd Al-Raheem
Al-Naqeeb, Tabarek Hadi
Moustafa, Shatha Rouf
Maes, Michael
description Many biochemical, immunological, and neuropsychiatric changes are associated with end-stage renal disease (ESRD). Neuronal damage biomarkers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), S100 calcium-binding protein B (S100B), ionized calcium-binding adaptor molecule-1 (IBA1), and myelin basic protein (MBP) are among the less-studied biomarkers of ESRD. We examined the associations between these neuro-axis biomarkers, inflammatory biomarkers, e.g., C-reactive protein (CRP), interleukin (IL-6), IL-10, and zinc, copper, and neuropsychiatric symptoms due to ERSD. ELISA techniques were used to measure serum levels of neuronal damage biomarkers in 70 ESRD patients, and 46 healthy controls. ESRD patients have higher scores of depression, anxiety, fatigue, and physiosomatic symptoms than healthy controls. Aberrations in kidney function tests and the number of dialysis interventions are associated with the severity of depression, anxiety, fibro-fatigue and physiosomatic symptoms, peripheral inflammation, nestin, and NFL. Serum levels of neuronal damage biomarkers (NFL, MBP, and nestin), CRP, and interleukin (IL)-10 are elevated, and serum zinc is decreased in ESRD patients as compared with controls. The neuronal damage biomarkers NFL, nestin, S100B and MBP are associated with the severity of one or more neuropsychiatric symptom domains. Around 50 % of the variance in the neuropsychiatric symptoms is explained by NFL, nestin, S00B, copper, and an inflammatory index. The severity of renal dysfunction and/or the number of dialysis interventions may induce peripheral inflammation and, consequently, neurotoxicity to intermediate filament proteins, astrocytes, and the blood-brain barrier, leading to the neuropsychiatric symptoms of ESRD. •ESRD patients have higher scores of depression, anxiety, and fatigue.•Kidney function decline and dialysis treatments cause peripheral inflammation.•NFL, MBP, and nestin are associated with the severity of neuropsychiatric symptoms.•Serum levels of NFL, MBP, nestin, CRP, and IL-10 are elevated in ESRD patients.
doi_str_mv 10.1016/j.jad.2023.11.078
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2893841894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165032723014465</els_id><sourcerecordid>2893841894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c305t-96a99e878dee36e59d2c8f415a2e311e0f94f56e710f084550736dcba014e5e93</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhS0EokvhB3BBPnJJGMdxYosTqoAiVXCBs-W1x11vk3ixnaL9E_xmvN3CkZOl8ffeaN4j5DWDlgEb3u3bvXFtBx1vGWthlE_IhomRN51g41OyqYxogHfjBXmR8x4ABjXCc3LBJcDIoN-Q319xTXExE3VmNrdIzeJoWPxk5tmUmI50G-Js0h2mTE2q_zlHG0xBR3-FsqNlV2feoy3h_qy2u2oYLPWmhNsVmyncIc3H-VDinKlbkZZIcXFNLqeFCR-2h4wm40vyzJsp46vH95L8-PTx-9V1c_Pt85erDzeN5SBKowajFMpROkQ-oFCus9L3TJgOOWMIXvVeDFhv9CB7IWDkg7NbA6xHgYpfkrdn30OKP1fMRc8hW5wms2Bcs-6k4rJnUvUVZWfUpphzQq8PKdREjpqBPtWg97rWoE81aMZ0raFq3jzar9sZ3T_F39wr8P4MYD3yPmDS2QZcLLqQapTaxfAf-z8Odppz</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2893841894</pqid></control><display><type>article</type><title>Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Al-Hakeim, Hussein Kadhem ; Twaij, Basim Abd Al-Raheem ; Al-Naqeeb, Tabarek Hadi ; Moustafa, Shatha Rouf ; Maes, Michael</creator><creatorcontrib>Al-Hakeim, Hussein Kadhem ; Twaij, Basim Abd Al-Raheem ; Al-Naqeeb, Tabarek Hadi ; Moustafa, Shatha Rouf ; Maes, Michael</creatorcontrib><description>Many biochemical, immunological, and neuropsychiatric changes are associated with end-stage renal disease (ESRD). Neuronal damage biomarkers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), S100 calcium-binding protein B (S100B), ionized calcium-binding adaptor molecule-1 (IBA1), and myelin basic protein (MBP) are among the less-studied biomarkers of ESRD. We examined the associations between these neuro-axis biomarkers, inflammatory biomarkers, e.g., C-reactive protein (CRP), interleukin (IL-6), IL-10, and zinc, copper, and neuropsychiatric symptoms due to ERSD. ELISA techniques were used to measure serum levels of neuronal damage biomarkers in 70 ESRD patients, and 46 healthy controls. ESRD patients have higher scores of depression, anxiety, fatigue, and physiosomatic symptoms than healthy controls. Aberrations in kidney function tests and the number of dialysis interventions are associated with the severity of depression, anxiety, fibro-fatigue and physiosomatic symptoms, peripheral inflammation, nestin, and NFL. Serum levels of neuronal damage biomarkers (NFL, MBP, and nestin), CRP, and interleukin (IL)-10 are elevated, and serum zinc is decreased in ESRD patients as compared with controls. The neuronal damage biomarkers NFL, nestin, S100B and MBP are associated with the severity of one or more neuropsychiatric symptom domains. Around 50 % of the variance in the neuropsychiatric symptoms is explained by NFL, nestin, S00B, copper, and an inflammatory index. The severity of renal dysfunction and/or the number of dialysis interventions may induce peripheral inflammation and, consequently, neurotoxicity to intermediate filament proteins, astrocytes, and the blood-brain barrier, leading to the neuropsychiatric symptoms of ESRD. •ESRD patients have higher scores of depression, anxiety, and fatigue.•Kidney function decline and dialysis treatments cause peripheral inflammation.•NFL, MBP, and nestin are associated with the severity of neuropsychiatric symptoms.•Serum levels of NFL, MBP, nestin, CRP, and IL-10 are elevated in ESRD patients.</description><identifier>ISSN: 0165-0327</identifier><identifier>EISSN: 1573-2517</identifier><identifier>DOI: 10.1016/j.jad.2023.11.078</identifier><identifier>PMID: 38007104</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Biomarkers ; C-Reactive Protein ; Copper ; Fatigue Syndrome, Chronic ; Humans ; Inflammation ; Interleukins ; Kidney Failure, Chronic ; Mood disorders ; Nestin ; Neuro-immune ; Neurotoxicity ; Psychiatry ; Zinc</subject><ispartof>Journal of affective disorders, 2024-02, Vol.347, p.220-229</ispartof><rights>2023 Elsevier B.V.</rights><rights>Copyright © 2023 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c305t-96a99e878dee36e59d2c8f415a2e311e0f94f56e710f084550736dcba014e5e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165032723014465$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38007104$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Hakeim, Hussein Kadhem</creatorcontrib><creatorcontrib>Twaij, Basim Abd Al-Raheem</creatorcontrib><creatorcontrib>Al-Naqeeb, Tabarek Hadi</creatorcontrib><creatorcontrib>Moustafa, Shatha Rouf</creatorcontrib><creatorcontrib>Maes, Michael</creatorcontrib><title>Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease</title><title>Journal of affective disorders</title><addtitle>J Affect Disord</addtitle><description>Many biochemical, immunological, and neuropsychiatric changes are associated with end-stage renal disease (ESRD). Neuronal damage biomarkers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), S100 calcium-binding protein B (S100B), ionized calcium-binding adaptor molecule-1 (IBA1), and myelin basic protein (MBP) are among the less-studied biomarkers of ESRD. We examined the associations between these neuro-axis biomarkers, inflammatory biomarkers, e.g., C-reactive protein (CRP), interleukin (IL-6), IL-10, and zinc, copper, and neuropsychiatric symptoms due to ERSD. ELISA techniques were used to measure serum levels of neuronal damage biomarkers in 70 ESRD patients, and 46 healthy controls. ESRD patients have higher scores of depression, anxiety, fatigue, and physiosomatic symptoms than healthy controls. Aberrations in kidney function tests and the number of dialysis interventions are associated with the severity of depression, anxiety, fibro-fatigue and physiosomatic symptoms, peripheral inflammation, nestin, and NFL. Serum levels of neuronal damage biomarkers (NFL, MBP, and nestin), CRP, and interleukin (IL)-10 are elevated, and serum zinc is decreased in ESRD patients as compared with controls. The neuronal damage biomarkers NFL, nestin, S100B and MBP are associated with the severity of one or more neuropsychiatric symptom domains. Around 50 % of the variance in the neuropsychiatric symptoms is explained by NFL, nestin, S00B, copper, and an inflammatory index. The severity of renal dysfunction and/or the number of dialysis interventions may induce peripheral inflammation and, consequently, neurotoxicity to intermediate filament proteins, astrocytes, and the blood-brain barrier, leading to the neuropsychiatric symptoms of ESRD. •ESRD patients have higher scores of depression, anxiety, and fatigue.•Kidney function decline and dialysis treatments cause peripheral inflammation.•NFL, MBP, and nestin are associated with the severity of neuropsychiatric symptoms.•Serum levels of NFL, MBP, nestin, CRP, and IL-10 are elevated in ESRD patients.</description><subject>Biomarkers</subject><subject>C-Reactive Protein</subject><subject>Copper</subject><subject>Fatigue Syndrome, Chronic</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Interleukins</subject><subject>Kidney Failure, Chronic</subject><subject>Mood disorders</subject><subject>Nestin</subject><subject>Neuro-immune</subject><subject>Neurotoxicity</subject><subject>Psychiatry</subject><subject>Zinc</subject><issn>0165-0327</issn><issn>1573-2517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhS0EokvhB3BBPnJJGMdxYosTqoAiVXCBs-W1x11vk3ixnaL9E_xmvN3CkZOl8ffeaN4j5DWDlgEb3u3bvXFtBx1vGWthlE_IhomRN51g41OyqYxogHfjBXmR8x4ABjXCc3LBJcDIoN-Q319xTXExE3VmNrdIzeJoWPxk5tmUmI50G-Js0h2mTE2q_zlHG0xBR3-FsqNlV2feoy3h_qy2u2oYLPWmhNsVmyncIc3H-VDinKlbkZZIcXFNLqeFCR-2h4wm40vyzJsp46vH95L8-PTx-9V1c_Pt85erDzeN5SBKowajFMpROkQ-oFCus9L3TJgOOWMIXvVeDFhv9CB7IWDkg7NbA6xHgYpfkrdn30OKP1fMRc8hW5wms2Bcs-6k4rJnUvUVZWfUpphzQq8PKdREjpqBPtWg97rWoE81aMZ0raFq3jzar9sZ3T_F39wr8P4MYD3yPmDS2QZcLLqQapTaxfAf-z8Odppz</recordid><startdate>20240215</startdate><enddate>20240215</enddate><creator>Al-Hakeim, Hussein Kadhem</creator><creator>Twaij, Basim Abd Al-Raheem</creator><creator>Al-Naqeeb, Tabarek Hadi</creator><creator>Moustafa, Shatha Rouf</creator><creator>Maes, Michael</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240215</creationdate><title>Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease</title><author>Al-Hakeim, Hussein Kadhem ; Twaij, Basim Abd Al-Raheem ; Al-Naqeeb, Tabarek Hadi ; Moustafa, Shatha Rouf ; Maes, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c305t-96a99e878dee36e59d2c8f415a2e311e0f94f56e710f084550736dcba014e5e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Biomarkers</topic><topic>C-Reactive Protein</topic><topic>Copper</topic><topic>Fatigue Syndrome, Chronic</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Interleukins</topic><topic>Kidney Failure, Chronic</topic><topic>Mood disorders</topic><topic>Nestin</topic><topic>Neuro-immune</topic><topic>Neurotoxicity</topic><topic>Psychiatry</topic><topic>Zinc</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Hakeim, Hussein Kadhem</creatorcontrib><creatorcontrib>Twaij, Basim Abd Al-Raheem</creatorcontrib><creatorcontrib>Al-Naqeeb, Tabarek Hadi</creatorcontrib><creatorcontrib>Moustafa, Shatha Rouf</creatorcontrib><creatorcontrib>Maes, Michael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of affective disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Hakeim, Hussein Kadhem</au><au>Twaij, Basim Abd Al-Raheem</au><au>Al-Naqeeb, Tabarek Hadi</au><au>Moustafa, Shatha Rouf</au><au>Maes, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease</atitle><jtitle>Journal of affective disorders</jtitle><addtitle>J Affect Disord</addtitle><date>2024-02-15</date><risdate>2024</risdate><volume>347</volume><spage>220</spage><epage>229</epage><pages>220-229</pages><issn>0165-0327</issn><eissn>1573-2517</eissn><abstract>Many biochemical, immunological, and neuropsychiatric changes are associated with end-stage renal disease (ESRD). Neuronal damage biomarkers such as glial fibrillary acidic protein (GFAP), neurofilament light chain (NFL), S100 calcium-binding protein B (S100B), ionized calcium-binding adaptor molecule-1 (IBA1), and myelin basic protein (MBP) are among the less-studied biomarkers of ESRD. We examined the associations between these neuro-axis biomarkers, inflammatory biomarkers, e.g., C-reactive protein (CRP), interleukin (IL-6), IL-10, and zinc, copper, and neuropsychiatric symptoms due to ERSD. ELISA techniques were used to measure serum levels of neuronal damage biomarkers in 70 ESRD patients, and 46 healthy controls. ESRD patients have higher scores of depression, anxiety, fatigue, and physiosomatic symptoms than healthy controls. Aberrations in kidney function tests and the number of dialysis interventions are associated with the severity of depression, anxiety, fibro-fatigue and physiosomatic symptoms, peripheral inflammation, nestin, and NFL. Serum levels of neuronal damage biomarkers (NFL, MBP, and nestin), CRP, and interleukin (IL)-10 are elevated, and serum zinc is decreased in ESRD patients as compared with controls. The neuronal damage biomarkers NFL, nestin, S100B and MBP are associated with the severity of one or more neuropsychiatric symptom domains. Around 50 % of the variance in the neuropsychiatric symptoms is explained by NFL, nestin, S00B, copper, and an inflammatory index. The severity of renal dysfunction and/or the number of dialysis interventions may induce peripheral inflammation and, consequently, neurotoxicity to intermediate filament proteins, astrocytes, and the blood-brain barrier, leading to the neuropsychiatric symptoms of ESRD. •ESRD patients have higher scores of depression, anxiety, and fatigue.•Kidney function decline and dialysis treatments cause peripheral inflammation.•NFL, MBP, and nestin are associated with the severity of neuropsychiatric symptoms.•Serum levels of NFL, MBP, nestin, CRP, and IL-10 are elevated in ESRD patients.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38007104</pmid><doi>10.1016/j.jad.2023.11.078</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-0327
ispartof Journal of affective disorders, 2024-02, Vol.347, p.220-229
issn 0165-0327
1573-2517
language eng
recordid cdi_proquest_miscellaneous_2893841894
source MEDLINE; Elsevier ScienceDirect Journals
subjects Biomarkers
C-Reactive Protein
Copper
Fatigue Syndrome, Chronic
Humans
Inflammation
Interleukins
Kidney Failure, Chronic
Mood disorders
Nestin
Neuro-immune
Neurotoxicity
Psychiatry
Zinc
title Neuronal damage and inflammatory biomarkers are associated with the affective and chronic fatigue-like symptoms due to end-stage renal disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T14%3A56%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuronal%20damage%20and%20inflammatory%20biomarkers%20are%20associated%20with%20the%20affective%20and%20chronic%20fatigue-like%20symptoms%20due%20to%20end-stage%20renal%20disease&rft.jtitle=Journal%20of%20affective%20disorders&rft.au=Al-Hakeim,%20Hussein%20Kadhem&rft.date=2024-02-15&rft.volume=347&rft.spage=220&rft.epage=229&rft.pages=220-229&rft.issn=0165-0327&rft.eissn=1573-2517&rft_id=info:doi/10.1016/j.jad.2023.11.078&rft_dat=%3Cproquest_cross%3E2893841894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2893841894&rft_id=info:pmid/38007104&rft_els_id=S0165032723014465&rfr_iscdi=true